Optimal strength and timing of steroids in the management of erlotinib-related skin toxicities in a post-marketing surveillance study (POLARSTAR) of 9909 non-small-cell lung cancer patients

BACKGROUND: Skin toxicities, such as rash, are the most common adverse reactions associated with erlotinib. Steroids are a key treatment option for rash management; however, optimal timing of administration and selection of steroid strength have not been fully established. In this surveillance study...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Naoya, Kiyohara, Yoshio, Kudoh, Shoji, Seki, Akihiro, Fukuoka, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824834/
https://www.ncbi.nlm.nih.gov/pubmed/26499382
http://dx.doi.org/10.1007/s10147-015-0893-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824834/
https://www.ncbi.nlm.nih.gov/pubmed/26499382
http://dx.doi.org/10.1007/s10147-015-0893-5

Ejemplares similares